Complete Filing Data
BridgeBio Pharma, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of -$2.08 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BridgeBio Pharma, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$732.9M | -$543.3M | -$653.3M | -$484.7M | -$586.5M | -$505.5M | -$288.6M | -$169.5M | -$43.8M |
| Cost of Revenue * | $21.0M | $3.9M | $2.4M | $3.4M | $3.1M | ||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $4.0K | -$23.0K | $359.0K | -$196.0K | -$324.0K | -$62.0K | $254.0K | ||
| Net Income Loss Excluding Redeemable Noncontrolling Interests Net Income Loss | -$726.7M | -$717.3M | -$648.1M | -$479.2M | -$581.1M | -$500.9M | -$285.7M | -$156.9M | -$41.1M |
| Research And Development Expense | $452.0M | $506.5M | $455.7M | $399.5M | $451.0M | $337.0M | $209.9M | $140.1M | $30.6M |
| Operating Income Loss | -$523.4M | -$593.0M | -$607.4M | -$512.2M | -$576.6M | -$474.5M | -$266.2M | -$183.7M | -$43.9M |
| Nonoperating Income Expense | -$209.1M | $50.8M | -$45.9M | $27.6M | -$9.8M | -$31.0M | -$22.3M | $14.2M | $26.0K |
| Net Income Loss Available To Common Stockholders Basic | -$724.9M | -$535.8M | -$643.2M | -$481.2M | -$562.5M | -$448.7M | -$260.6M | -$130.7M | -$30.6M |
| Net Income Loss Attributable To Noncontrolling Interest | -$8.0M | -$7.6M | -$10.0M | -$3.5M | -$23.9M | -$56.8M | -$28.0M | -$38.7M | -$13.3M |
| Comprehensive Income Net Of Tax | -$724.9M | -$535.8M | -$642.8M | -$481.4M | -$562.9M | -$448.8M | -$260.3M | -$130.7M | -$30.6M |
| Other Nonoperating Income Expense | $43.1M | $12.3M | $17.4M | -$7.5M | $35.8M | $1.6M | -$1.6M | -$4.3M | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$732.9M | -$543.4M | -$652.9M | -$484.8M | -$586.8M | -$505.6M | -$288.3M | -$169.5M | -$43.8M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$8.0M | -$7.6M | -$10.0M | -$3.5M | -$23.9M | -$56.8M | -$28.0M | -$38.7M | -$13.3M |
| Revenue From Contract With Customer Excluding Assessed Tax | $502.1M | $221.9M | $9.3M | $77.6M | $69.7M | $8.2M | $40.6M | ||
| Interest Expense | $81.3M | $80.4M | $46.8M | $36.7M | $8.8M | $2.5M | $13.0K | ||
| Selling General And Administrative Expense | $531.2M | $288.9M | $150.6M | $143.2M | $192.2M | $145.7M | $94.4M | ||
| Accrued Research And Development Liabilities Current | $41.4M | $34.3M | $29.8M | $39.8M | $44.1M | $27.3M | $20.9M | $8.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$184.9M | -$183.8M | -$169.6M | -$164.3M | -$75.5M | -$36.2M | -$179.5M | -$160.7M | -$142.7M | -$140.2M | -$2.6M | -$201.3M | -$161.0M | -$102.1M | -$171.1M | -$130.2M | -$136.2M | -$104.1M | -$60.7M | -$69.0K | -$69.4M | -$42.1M | ||
| Cost of Revenue * | $6.6M | $3.7M | $2.6M | $598.0K | $598.0K | $598.0K | $598.0K | $599.0K | $651.0K | $739.0K | $700.0K | $1.5M | $109.0K | $0.00 | ||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $1.0K | $1.0K | -$8.0K | $9.0K | -$6.0K | -$29.0K | -$29.0K | $75.0K | $316.0K | $79.0K | -$44.0K | -$251.0K | -$17.0K | $93.0K | -$249.0K | -$397.0K | $132.0K | $472.0K | $152.0K | |||||
| Net Income Loss Excluding Redeemable Noncontrolling Interests Net Income Loss | -$183.3M | -$182.4M | -$168.1M | -$215.2M | -$201.0M | -$34.9M | -$177.9M | -$159.3M | -$141.6M | -$139.2M | -$580.0K | -$200.3M | -$159.7M | -$100.5M | -$170.2M | -$129.0M | -$134.6M | -$103.2M | -$60.0M | -$73.6M | -$68.6M | -$39.7M | -$32.1M | -$38.8M |
| Research And Development Expense | $112.9M | $111.2M | $111.4M | $120.4M | $114.7M | $141.0M | $125.1M | $107.5M | $92.9M | $92.5M | $108.4M | $107.6M | $104.3M | $102.0M | $122.6M | $92.1M | $86.6M | $68.2M | $55.3M | $52.3M | $44.9M | $31.1M | ||
| Operating Income Loss | -$145.2M | -$134.3M | -$104.4M | -$191.8M | -$175.5M | $343.0K | -$157.7M | -$146.1M | -$126.2M | -$129.1M | -$80.2M | -$173.7M | -$149.5M | -$94.0M | -$167.5M | -$119.9M | -$124.6M | -$102.5M | -$54.5M | -$69.3M | -$63.8M | -$41.5M | ||
| Nonoperating Income Expense | -$41.3M | -$47.4M | -$65.2M | $27.5M | $100.0M | -$36.5M | -$21.8M | -$14.6M | -$16.6M | -$11.1M | $77.6M | -$27.7M | -$11.5M | -$8.1M | -$3.6M | -$10.2M | -$11.6M | -$1.6M | -$6.1M | -$5.0M | -$5.7M | -$622.0K | ||
| Net Income Loss Available To Common Stockholders Basic | -$182.7M | -$181.9M | -$167.4M | -$162.0M | -$73.5M | -$35.2M | -$177.0M | -$157.9M | -$140.2M | -$137.3M | -$9.9M | -$196.4M | -$155.9M | -$96.3M | -$163.1M | -$115.9M | -$121.0M | -$91.9M | -$60.0M | -$66.0M | -$61.2M | -$31.4M | ||
| Net Income Loss Attributable To Noncontrolling Interest | -$2.2M | -$1.9M | -$2.2M | -$2.2M | -$2.1M | -$944.0K | -$2.5M | -$2.8M | -$2.6M | -$2.9M | $7.3M | -$4.9M | -$5.1M | -$5.7M | -$8.0M | -$14.3M | -$15.2M | -$12.2M | -$684.0K | -$8.4M | -$8.3M | -$10.7M | ||
| Comprehensive Income Net Of Tax | -$182.7M | -$181.9M | -$167.4M | -$162.0M | -$73.5M | -$35.2M | -$177.0M | -$157.8M | -$139.8M | -$137.3M | -$9.9M | -$196.6M | -$156.0M | -$96.3M | -$163.3M | -$116.3M | -$120.9M | -$91.4M | -$59.8M | -$66.0M | -$61.2M | -$42.1M | ||
| Other Nonoperating Income Expense | $16.5M | $6.5M | $8.2M | $1.8M | -$632.0K | $9.5M | -$5.3M | $1.5M | -$601.0K | $6.3M | -$10.8M | -$7.6M | -$684.0K | $2.5M | $5.8M | $9.0K | -$1.8M | $474.0K | -$166.0K | $219.0K | -$1.5M | $6.0K | ||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$184.9M | -$183.8M | -$169.6M | -$164.2M | -$75.6M | -$36.2M | -$179.5M | -$160.6M | -$142.4M | -$140.1M | -$2.6M | -$201.6M | -$161.0M | -$102.0M | -$171.3M | -$130.6M | -$136.1M | -$103.6M | -$60.5M | -$74.3M | -$69.4M | |||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$2.2M | -$1.9M | -$2.2M | -$2.2M | -$2.1M | -$944.0K | -$2.5M | -$2.8M | -$2.6M | -$2.9M | $7.3M | -$4.9M | -$5.1M | -$5.7M | -$8.0M | -$14.3M | -$15.2M | -$12.2M | -$684.0K | -$8.4M | -$8.3M | |||
| Revenue From Contract With Customer Excluding Assessed Tax | $120.7M | $110.6M | $116.6M | $2.7M | $2.2M | $211.1M | $4.1M | $1.6M | $1.8M | $338.0K | $73.7M | $1.7M | $2.3M | $54.0M | $462.0K | $8.1M | $26.7M | |||||||
| Interest Expense | $22.9M | $23.5M | $20.3M | $20.6M | $20.1M | $19.8M | $20.3M | $20.3M | $11.1M | $10.8M | $9.7M | $10.9M | $10.8M | $4.0M | $2.1M | $1.9M | $1.7M | $1.2M | ||||||
| Selling General And Administrative Expense | $137.6M | $129.2M | $106.4M | $68.8M | $59.5M | $65.8M | $35.8M | $36.1M | $31.1M | $31.2M | $36.4M | $43.7M | $46.1M | $46.0M | $45.4M | $36.0M | $38.0M | |||||||
| Accrued Research And Development Liabilities Current | $34.6M | $31.3M | $33.6M | $41.0M | $33.2M | $40.9M | $29.2M | $28.3M | $37.1M | $44.6M | $50.1M | $43.3M | $37.6M | $55.6M | $33.4M | $24.9M | $37.2M | $29.5M | $13.2M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$2.09B | -$1.47B | -$1.35B | -$1.25B | -$870.4M | $57.9M | $408.5M | $314.9M | $85.9M | $14.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $572.1M | $683.2M | $394.7M | $416.9M | $396.4M | $358.7M | $364.2M | $436.2M | $92.4M | $20.3M |
| Minority Interest Period Increase Decrease | -$3.4M | -$4.0M | -$4.9M | -$2.4M | $3.5M | -$1.8M | -$1.8M | $51.7M | $769.0K | |
| Cash And Cash Equivalents At Carrying Value | $570.1M | $681.1M | $375.9M | $376.7M | $393.8M | $356.1M | $363.8M | $436.1M | $92.0M | |
| Minority Interest | $10.6M | $10.2M | $11.2M | $11.3M | $3.4M | $48.4M | $65.3M | $62.4M | $2.5M | $2.6M |
| Common Stock Value | $202.0K | $196.0K | $181.0K | $157.0K | $154.0K | $125.0K | $124.0K | $92.0K | $51.0K | $21.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$111.1M | $288.5M | -$22.2M | $20.5M | $37.7M | -$5.5M | -$72.0M | $343.9M | $72.0M | |
| Retained Earnings Accumulated Deficit | -$3.82B | -$3.10B | -$2.56B | -$1.92B | -$1.44B | -$888.8M | -$440.0M | -$179.4M | -$48.7M | -$18.1M |
| Additional Paid In Capital Common Stock | $1.48B | $938.7M | $841.5M | $1.02B | $848.1M | $494.2M | $134.5M | $33.0M | ||
| Property Plant And Equipment Net | $5.4M | $7.0M | $11.8M | $14.6M | $30.1M | $20.3M | $5.6M | $1.6M | ||
| Prepaid Expense And Other Assets Current | $44.1M | $34.9M | $24.3M | $21.9M | $32.3M | $35.7M | $19.8M | $9.1M | ||
| Other Liabilities Noncurrent | $244.0K | $286.0K | $5.6M | $26.6M | $22.1M | $9.5M | $3.5M | $495.0K | ||
| Other Assets Noncurrent | $16.7M | $18.2M | $22.6M | $20.2M | $33.0M | $23.9M | $26.3M | $1.1M | ||
| Liabilities Current | $288.0M | $154.4M | $143.8M | $121.4M | $135.1M | $95.6M | $60.4M | $32.6M | ||
| Liabilities And Stockholders Equity | $936.0M | $919.3M | $546.4M | $623.0M | $1.01B | $703.6M | $631.7M | $464.9M | ||
| Liabilities | $3.01B | $2.38B | $1.89B | $1.87B | $1.88B | $595.7M | $155.7M | $87.6M | ||
| Employee Related Liabilities Current | $76.7M | $58.3M | $57.4M | $31.3M | $37.0M | $29.7M | $13.3M | $4.0M | ||
| Assets Current | $797.7M | $720.7M | $477.6M | $548.9M | $888.9M | $642.8M | $568.6M | $445.2M | ||
| Assets | $936.0M | $919.3M | $546.4M | $623.0M | $1.01B | $703.6M | $631.7M | $464.9M | ||
| Accounts Payable Current | $36.2M | $9.6M | $10.7M | $11.6M | $11.9M | $8.9M | $8.9M | $13.5M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $12.0K | $8.0K | $31.0K | -$328.0K | -$132.0K | $192.0K | $254.0K | |||
| Operating Lease Right Of Use Asset | $8.1M | $5.8M | $8.0M | $10.7M | $15.9M | $16.5M | ||||
| Operating Lease Liability Noncurrent | $3.8M | $4.7M | $9.0M | $12.3M | $17.4M | $14.7M | ||||
| Operating Lease Liability Current | $6.2M | $4.5M | $4.1M | $3.7M | $4.9M | $3.8M | ||||
| Long Term Debt Noncurrent | $446.4M | $431.0M | $430.8M | $92.4M | $91.8M | $54.5M | ||||
| Equity Securities Fv Ni Gain Loss | $0.00 | $8.1M | $18.3M | -$8.2M | $29.9M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$1.93B | -$1.79B | -$1.65B | -$1.23B | -$1.09B | -$1.05B | -$1.21B | -$1.36B | -$1.23B | -$1.14B | -$1.03B | -$1.04B | -$743.4M | -$464.3M | -$395.3M | $163.8M | $265.8M | $380.7M | $459.8M | $162.9M | $252.1M | $165.9M | $204.4M | $61.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $645.1M | $751.1M | $542.7M | $407.9M | $549.5M | $477.5M | $524.1M | $324.6M | $435.1M | $485.8M | $472.6M | $374.2M | $183.1M | $381.1M | $473.8M | $367.4M | $541.3M | $757.5M | $414.4M | $294.2M | $373.0M | $212.1M | |||
| Minority Interest Period Increase Decrease | -$2.1M | -$400.0K | -$379.0K | -$1.9M | -$106.0K | -$1.3M | -$1.1M | -$1.9M | -$1.6M | -$65.0K | -$144.0K | $48.0K | $362.0K | $3.6M | -$517.0K | -$799.0K | -$431.0K | -$574.0K | $166.0K | -$658.0K | -$870.0K | -$75.0K | $41.5M | $11.3M | |
| Cash And Cash Equivalents At Carrying Value | $643.0M | $749.0M | $540.6M | $266.3M | $408.0M | $475.2M | $505.2M | $302.4M | $407.4M | $483.2M | $470.1M | $371.6M | $180.3M | $378.4M | $471.2M | $367.0M | $540.9M | $757.0M | $414.0M | $293.8M | $373.0M | $211.7M | |||
| Minority Interest | $10.3M | $9.9M | $10.0M | $10.9M | $11.1M | $12.1M | $12.4M | $12.1M | $12.3M | $10.4M | $12.0M | -$27.0K | $4.6M | $6.8M | $5.9M | $52.1M | $59.8M | $68.3M | $61.9M | $48.4M | $58.3M | ||||
| Common Stock Value | $200.0K | $198.0K | $197.0K | $195.0K | $194.0K | $193.0K | $180.0K | $168.0K | $167.0K | $156.0K | $154.0K | $154.0K | $153.0K | $153.0K | $152.0K | $125.0K | $125.0K | $124.0K | $117.0K | $92.0K | $92.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$140.5M | $82.8M | $18.2M | -$22.2M | $115.1M | $393.3M | -$63.2M | ||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$3.63B | -$3.45B | -$3.26B | -$2.83B | -$2.67B | -$2.60B | -$2.39B | -$2.22B | -$2.06B | -$1.78B | -$1.64B | -$1.63B | -$1.29B | -$1.13B | -$1.04B | -$768.8M | -$652.9M | -$531.9M | -$366.6M | -$306.6M | -$240.6M | ||||
| Additional Paid In Capital Common Stock | $1.98B | $1.94B | $1.90B | $1.88B | $1.85B | $1.82B | $1.46B | $1.13B | $1.11B | $917.3M | $893.0M | $867.6M | $821.2M | $799.7M | $767.1M | $1.01B | $992.7M | $986.7M | $826.1M | $469.4M | $492.7M | ||||
| Property Plant And Equipment Net | $5.8M | $6.1M | $6.7M | $8.7M | $9.8M | $11.4M | $12.4M | $13.0M | $13.6M | $15.6M | $16.9M | $17.2M | $27.7M | $26.3M | $22.8M | $16.2M | $15.6M | $15.8M | $3.0M | ||||||
| Prepaid Expense And Other Assets Current | $52.4M | $60.2M | $35.4M | $38.4M | $28.4M | $28.1M | $22.6M | $20.5M | $25.1M | $25.7M | $32.8M | $34.0M | $31.9M | $26.7M | $25.5M | $26.7M | $21.0M | $19.8M | $22.1M | ||||||
| Other Liabilities Noncurrent | $679.0K | $545.0K | $352.0K | $377.0K | $485.0K | $595.0K | $11.8M | $13.3M | $17.5M | $28.2M | $28.6M | $26.8M | $27.6M | $13.3M | $11.6M | $13.5M | $9.4M | $2.8M | $1.4M | ||||||
| Other Assets Noncurrent | $25.5M | $18.1M | $16.6M | $20.3M | $18.9M | $20.7M | $18.7M | $20.4M | $20.8M | $29.9M | $31.3M | $35.3M | $33.1M | $49.8M | $30.2M | $16.5M | $17.3M | $17.0M | $2.6M | ||||||
| Liabilities Current | $216.6M | $175.9M | $152.1M | $139.2M | $134.4M | $141.5M | $106.1M | $110.1M | $96.6M | $119.2M | $141.2M | $103.5M | $95.8M | $131.9M | $94.7M | $75.7M | $92.6M | $64.9M | $39.9M | ||||||
| Liabilities And Stockholders Equity | $998.3M | $1.08B | $881.6M | $665.0M | $794.4M | $849.3M | $655.0M | $503.7M | $625.7M | $728.7M | $862.2M | $813.1M | $781.5M | $1.08B | $1.09B | $787.7M | $905.2M | $989.8M | $640.5M | ||||||
| Liabilities | $2.92B | $2.86B | $2.52B | $1.88B | $1.88B | $1.89B | $1.85B | $1.85B | $1.84B | $1.86B | $1.88B | $1.85B | $1.52B | $1.54B | $1.48B | $569.3M | $577.7M | $537.7M | $116.3M | ||||||
| Employee Related Liabilities Current | $56.2M | $37.2M | $33.4M | $43.5M | $29.1M | $32.4M | $33.7M | $28.7M | $18.9M | $24.8M | $32.6M | $15.5M | $21.6M | $21.9M | $20.7M | $18.8M | $13.6M | $5.6M | $7.6M | ||||||
| Assets Current | $839.4M | $912.3M | $695.2M | $444.6M | $616.2M | $783.4M | $587.7M | $432.9M | $552.7M | $642.2M | $771.3M | $716.2M | $639.7M | $909.9M | $945.1M | $745.4M | $861.9M | $925.0M | $558.2M | ||||||
| Assets | $998.3M | $1.08B | $881.6M | $665.0M | $794.4M | $849.3M | $655.0M | $503.7M | $625.7M | $728.7M | $862.2M | $813.1M | $781.5M | $1.08B | $1.09B | $787.7M | $905.2M | $989.8M | $640.5M | ||||||
| Accounts Payable Current | $18.7M | $26.1M | $27.5M | $13.4M | $18.1M | $4.7M | $4.5M | $3.9M | $4.1M | $10.2M | $8.8M | $10.1M | $12.0M | $22.3M | $10.3M | $9.8M | $12.8M | $13.1M | $10.3M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $2.0K | $1.0K | $0.00 | $5.0K | -$4.0K | $2.0K | $34.0K | $63.0K | -$12.0K | -$348.0K | -$427.0K | -$383.0K | $19.0K | $36.0K | -$57.0K | $461.0K | $858.0K | $726.0K | $152.0K | ||||||
| Operating Lease Right Of Use Asset | $6.6M | $6.2M | $7.2M | $6.4M | $7.3M | $8.1M | $9.3M | $9.8M | $10.5M | $11.7M | $12.9M | $13.9M | $17.1M | $16.0M | $13.0M | $9.6M | $10.5M | $8.9M | |||||||
| Operating Lease Liability Noncurrent | $3.4M | $4.0M | $4.9M | $5.8M | $7.1M | $8.3M | $9.8M | $10.9M | $11.9M | $13.0M | $14.3M | $15.5M | $18.7M | $18.0M | $13.9M | $8.2M | $9.1M | $8.7M | |||||||
| Operating Lease Liability Current | $5.3M | $4.8M | $5.2M | $4.6M | $4.6M | $4.5M | $4.1M | $3.8M | $3.7M | $4.0M | $4.3M | $4.4M | $5.0M | $4.5M | $3.8M | $3.6M | $3.6M | $2.5M | |||||||
| Long Term Debt Noncurrent | $0.00 | $0.00 | $437.3M | $436.2M | $435.4M | $434.7M | $441.7M | $440.5M | $435.8M | $434.1M | $103.1M | $102.6M | $90.8M | $93.4M | $92.9M | $92.4M | $75.0M | ||||||||
| Equity Securities Fv Ni Gain Loss | $0.00 | $8.1M | $964.0K | -$10.4M | -$12.9M | -$1.1M | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $133.0M | $95.8M | $108.7M | $91.6M | $99.5M | $58.5M | $21.4M | $6.1M | $1.8M |
| Payments To Acquire Property Plant And Equipment | $1.1M | $933.0K | $1.3M | $4.8M | $13.2M | $7.5M | $2.6M | $2.2M | $464.0K |
| Net Cash Provided By Used In Operating Activities | -$445.9M | -$520.7M | -$527.7M | -$419.5M | -$497.9M | -$399.7M | -$253.6M | -$136.6M | -$40.5M |
| Net Cash Provided By Used In Investing Activities | -$24.5M | $60.8M | $54.0M | $453.1M | -$200.8M | -$53.0M | -$217.3M | -$21.0M | -$464.0K |
| Net Cash Provided By Used In Financing Activities | $359.3M | $748.5M | $451.5M | -$13.1M | $736.4M | $447.2M | $398.8M | $501.5M | $113.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $8.8M | $13.9M | $2.7M | -$7.7M | $4.3M | $7.1M | $10.6M | $6.1M | $4.3M |
| Increase Decrease In Other Operating Assets | -$1.1M | -$1.5M | $1.5M | -$11.0M | $9.8M | $2.1M | $16.9M | $843.0K | $92.0K |
| Increase Decrease In Employee Related Liabilities | $23.0M | $17.0M | $7.8M | -$2.4M | $7.4M | $8.6M | $9.3M | $3.4M | $1.1M |
| Increase Decrease In Accrued Research And Development Liabilities | $7.2M | $8.7M | -$9.9M | -$4.3M | $11.2M | $6.2M | $12.0M | $5.8M | $2.7M |
| Increase Decrease In Accounts Payable | $26.6M | $1.5M | $2.8M | -$349.0K | $2.8M | -$735.0K | -$4.7M | $16.7M | $1.6M |
| Proceeds From Stock Options Exercised | $27.7M | $3.7M | $6.0M | $666.0K | $16.6M | $12.9M | $1.8M | $440.0K | $144.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $4.2M | $3.5M | -$7.7M | $14.2M | $8.3M | $1.5M | $3.1M | $356.0K | |
| Proceeds From Stock Plans | $6.4M | $4.5M | $3.4M | $2.6M | $3.8M | $1.2M | $921.0K | ||
| Payments To Acquire Marketable Securities | $93.8M | $29.7M | $137.5M | $589.9M | $287.9M | $212.9M | |||
| Payments Related To Tax Withholding For Share Based Compensation | $14.2M | $7.5M | $6.9M | $1.6M | $4.7M | $714.0K | |||
| Depreciation Depletion And Amortization | $5.4M | $6.1M | $6.5M | $6.8M | $5.8M | $1.5M | $859.0K | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $95.0M | $82.6M | $479.7M | $380.2M | $249.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $25.9M | $17.1M | $21.9M | $24.1M | $33.6M | $10.2M | $2.2M |
| Payments To Acquire Property Plant And Equipment | $0.00 | $695.0K | $12.0K | $859.0K | $2.0M | $4.5M | $427.0K |
| Net Cash Provided By Used In Operating Activities | -$199.2M | -$219.5M | -$144.3M | -$160.6M | -$150.8M | -$83.9M | -$59.1M |
| Net Cash Provided By Used In Investing Activities | -$1.6M | $22.8M | $12.3M | $138.6M | -$282.1M | $38.0M | -$2.4M |
| Net Cash Provided By Used In Financing Activities | $60.3M | $279.5M | $150.2M | -$160.0K | $547.9M | $439.2M | -$1.7M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $487.0K | $3.3M | $3.5M | $2.7M | -$1.4M | -$1.0K | $309.0K |
| Increase Decrease In Other Operating Assets | -$1.6M | -$444.0K | $483.0K | -$7.9M | $6.1M | $734.0K | $1.9M |
| Increase Decrease In Employee Related Liabilities | -$19.4M | -$15.0M | -$18.4M | -$16.9M | -$13.0M | -$7.7M | -$432.0K |
| Increase Decrease In Accrued Research And Development Liabilities | -$642.0K | $11.2M | -$2.6M | -$818.0K | $6.1M | $8.6M | $1.7M |
| Increase Decrease In Accounts Payable | $17.6M | -$5.9M | -$3.8M | -$1.8M | $1.8M | $4.2M | -$2.0M |
| Proceeds From Stock Options Exercised | $2.5M | $537.0K | $193.0K | $104.0K | $7.5M | $734.0K | $103.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$1.3M | -$6.4M | -$2.9M | -$3.5M | $15.0K | $723.0K | |
| Proceeds From Stock Plans | $3.2M | $2.4M | $1.8M | $966.0K | $1.7M | ||
| Payments To Acquire Marketable Securities | $0.00 | $44.4M | $0.00 | $55.7M | $379.3M | ||
| Payments Related To Tax Withholding For Share Based Compensation | $1.8M | $2.9M | $512.0K | $110.0K | $1.0M | ||
| Depreciation Depletion And Amortization | $1.3M | $1.6M | $1.6M | $1.9M | $566.0K | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $0.00 | $18.0M | $186.7M | $99.2M | $42.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.78 | -$2.88 | -$3.95 | -$3.26 | -$3.90 | -$3.80 | -$2.48 | -$2.12 | -$1.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 194.8M | 190.0M | 175.1M | 150.6M | 147.3M | 122.8M | 123.7M | 92.1M | |
| Common Stock Shares Issued | 202.4M | 196.2M | 181.3M | 156.8M | 153.5M | 125.3M | 123.7M | 92.1M | |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 97.4M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 191.5M | 186.1M | 162.8M | 147.5M | 144.4M | 118.0M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 191.5M | 186.1M | 162.8M | 147.5M | 144.4M | 118.0M | |||
| Earnings Per Share Basic | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 | $-3.80 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.95 | -$0.95 | -$0.88 | -$0.86 | -$0.39 | -$0.20 | -$1.08 | -$0.98 | -$0.92 | -$0.93 | -$0.07 | -$1.35 | -$1.06 | -$0.66 | -$1.18 | -$0.98 | -$1.03 | -$0.78 | -$0.51 | -$0.71 | -$0.66 | -$0.52 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 192.6M | 191.2M | 189.8M | 189.0M | 188.0M | 187.1M | 174.1M | 161.4M | 160.4M | 149.4M | 148.2M | 147.7M | 147.1M | 149.6M | 149.1M | 122.5M | 122.3M | 121.4M | 117.4M | 0.00 | ||
| Common Stock Shares Issued | 200.2M | 198.8M | 197.4M | 195.2M | 194.2M | 193.3M | 180.3M | 167.6M | 166.6M | 155.6M | 154.4M | 153.9M | 153.3M | 152.9M | 152.3M | 125.0M | 124.7M | 123.8M | 117.4M | 0.00 | ||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 191.9M | 190.5M | 190.1M | 188.5M | 187.6M | 178.7M | 163.3M | 160.5M | 152.6M | 147.9M | 146.7M | 145.9M | 146.7M | 146.8M | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 191.9M | 190.5M | 190.1M | 188.5M | 187.6M | 178.7M | 163.3M | 160.5M | 152.6M | 147.9M | 146.7M | 145.9M | 146.7M | 146.8M | ||||||||
| Earnings Per Share Basic | $-0.95 | $-0.95 | $-0.88 | $-0.86 | $-0.39 | $-0.20 | $-1.08 | $-0.98 | $-0.92 | $-0.93 | $-0.07 | $-1.35 | $-1.06 | $-0.66 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Issuance Repurchase Of Noncontrolling Interest | $200.0K | -$2.0M | $4.8M | $6.2M | $50.8M | $1.2M | $55.2M | $1.4M | |
| Investment Income Interest | $19.9M | $17.2M | $18.0M | $7.5M | $1.1M | $4.0M | $8.9M | $2.0M | $39.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $140.2M | $112.0M | $98.6M | $94.2M | $89.8M | $36.5M | $15.2M | $3.2M | |
| Costs And Expenses | $1.03B | $814.9M | $616.7M | $589.9M | $646.3M | $482.7M | $306.8M | ||
| Interest Paid Net | $43.7M | $91.3M | $61.1M | $54.4M | $29.8M | $15.3M | $6.1M | $1.6M | |
| Other Noncash Income Expense | $1.7M | $935.0K | $803.0K | -$2.2M | -$7.1M | -$1.2M | $3.5M | -$252.0K | -$260.0K |
| Noncash Or Part Noncash Investing Transfer From To Noncontrolling Interest | -$5.6M | -$5.8M | -$10.5M | -$3.5M | -$2.1M | $12.0M | -$28.6M | $21.6M | -$8.2M |
| Accretion Expense | $15.8M | $8.9M | $8.6M | $5.8M | $17.7M | $1.5M | $783.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Issuance Repurchase Of Noncontrolling Interest | $164.0K | $35.0K | $41.0K | $40.0K | $42.0K | $77.0K | $4.7M | $89.0K | $640.0K | $5.0K | $5.1M | $7.3M | $3.5M | $26.6M | -$98.0K | -$27.0M | $1.3M | $974.0K | $96.7M | $553.0K | ||||
| Investment Income Interest | $6.2M | $3.9M | $5.4M | $3.3M | $5.2M | $4.1M | $3.8M | $4.5M | $4.2M | $2.4M | $766.0K | $267.0K | $234.0K | $323.0K | $394.0K | $692.0K | $934.0K | $1.9M | $2.7M | $1.7M | $2.1M | $528.0K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $35.6M | $38.1M | $32.1M | $26.6M | $31.5M | $27.1M | $24.2M | $24.6M | $24.3M | $23.2M | $23.9M | $25.4M | $16.9M | $32.5M | $19.8M | $11.7M | $7.3M | $8.1M | $69.0K | |||||
| Costs And Expenses | $265.9M | $244.8M | $221.0M | $194.5M | $177.7M | $210.8M | $161.8M | $147.7M | $128.0M | $129.5M | $153.9M | $175.4M | $151.8M | $148.0M | $168.0M | $128.1M | $124.6M | |||||||
| Interest Paid Net | $23.3M | $35.3M | $22.1M | $18.8M | $8.9M | $2.1M | $1.2M | |||||||||||||||||
| Other Noncash Income Expense | $4.0M | -$1.6M | $314.0K | -$604.0K | -$1.2M | -$493.0K | -$339.0K | |||||||||||||||||
| Noncash Or Part Noncash Investing Transfer From To Noncontrolling Interest | -$824.0K | -$1.9M | -$2.8M | -$317.0K | $1.7M | $11.6M | -$3.0M | |||||||||||||||||
| Accretion Expense | $25.6M | $2.0M | $2.3M | $2.5M | $1.2M | $1.8M | $354.0K |
Most recent annual filing with the SEC: February 24, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.